ARCHIVES

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

This article is from The Cancer Letter archive.

Vol. 38 No. 18 | May 4, 2012

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Treatment Studies Need Standard Definitions – Carbone

May 10, 1974

NCI Cooperative Group Clinical Trials Approved

September 25, 2009

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Fisher, Hallman Lecture At annual ASCO/AACR Meeting

May 9, 1980

1991 Bypass Budget Would Fund 50 Percent Of Competing Grants

May 26, 1989

NCI To Offer Planning Grants for New Centers

November 9, 1990